Literature DB >> 10648727

Behavioral evidence of depolarization block of dopamine neurons after chronic treatment with haloperidol and clozapine.

S M Boye1, P P Rompré.   

Abstract

Electrophysiological studies have shown that chronic treatment with haloperidol causes depolarization block (DB) of dopamine cells in anesthetized and paralyzed rats. It has been proposed that the emergence of DB underlies the therapeutic and side effects of this drug. However, the relevance of DB to the clinical actions of haloperidol has been questioned on the grounds that chronic drug-induced DB has not yet been demonstrated in freely moving animals. In this study, responding for rewarding electrical brain stimulation was used to assess the occurrence of DB in rats chronically treated with haloperidol or clozapine. The time course of the effects of acute haloperidol (7.8-500 microg/kg) and clozapine (5-40 mg/kg) and of withdrawal from chronic drug treatment on reward and performance measures were also characterized. Haloperidol and clozapine dose-dependently attenuated reward and performance, haloperidol producing a predominant suppression of performance, and clozapine preferentially attenuating reward. Chronic (21 d) treatment with haloperidol (500 microg/kg) caused responding to cease in the six rats tested, and repeated injection with apomorphine restored the behavior in all of them; such an effect of apomorphine was observed in only two of six rats treated acutely with the same dose of haloperidol. Chronic treatment with clozapine (20 mg/kg) increased reward thresholds, an effect that was reversed by apomorphine in chronically, but not acutely, treated rats. The times at which chronic haloperidol-treated rats resumed responding was positively correlated with indices of behavioral supersensitivity after withdrawal, suggesting that the effect of apomorphine was not caused by direct stimulation of upregulated postsynaptic receptors. These findings constitute the first behavioral evidence of DB in unanesthetized, freely moving animals treated chronically with antipsychotics. They also demonstrate that the neural substrates mediating reward and performance are functionally independent and differentially sensitive to haloperidol and clozapine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648727      PMCID: PMC6774188     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  Electrophysiological, biochemical, and behavioral studies of acute haloperidol-induced depolarization block of nigral dopamine neurons.

Authors:  J R Hollerman; E D Abercrombie; A A Grace
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

2.  Failure of chronic haloperidol to induce depolarization inactivation of dopamine neurons in unanesthetized rats.

Authors:  G Mereu; V Lilliu; P Vargiu; A L Muntoni; M Diana; G L Gessa
Journal:  Eur J Pharmacol       Date:  1994-11-03       Impact factor: 4.432

Review 3.  Addictive drugs and brain stimulation reward.

Authors:  R A Wise
Journal:  Annu Rev Neurosci       Date:  1996       Impact factor: 12.449

4.  Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin.

Authors:  A S Freeman; B S Bunney
Journal:  Brain Res       Date:  1987-03-03       Impact factor: 3.252

5.  Behavioural manifestations elicited by apomorphine, influence of the route of administration.

Authors:  H M Barros; S Braz; E A Carlini
Journal:  Pharmacology       Date:  1989       Impact factor: 2.547

6.  Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat.

Authors:  E L Gardner; L S Walker; W Paredes
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.

Authors:  N M Rupniak; M D Hall; S Mann; S Fleminger; G Kilpatrick; P Jenner; C D Marsden
Journal:  Biochem Pharmacol       Date:  1985-08-01       Impact factor: 5.858

8.  Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat.

Authors:  F J White; R Y Wang
Journal:  Life Sci       Date:  1983-02-28       Impact factor: 5.037

9.  Pimozide and amphetamine have opposing effects on the reward summation function.

Authors:  C R Gallistel; D Karras
Journal:  Pharmacol Biochem Behav       Date:  1984-01       Impact factor: 3.533

10.  The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.

Authors:  A Robertson; C MacDonald
Journal:  Pharmacol Biochem Behav       Date:  1986-06       Impact factor: 3.533

View more
  13 in total

1.  Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription.

Authors:  B Liss; O Franz; S Sewing; R Bruns; H Neuhoff; J Roeper
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

Review 2.  Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients.

Authors:  Richard J Beninger; Tyson W Baker; Matthew M Florczynski; Tomek J Banasikowski
Journal:  Neurotox Res       Date:  2010-04-08       Impact factor: 3.911

3.  Antipsychotic drug-induced increases in ventral tegmental area dopamine neuron population activity via activation of the nucleus accumbens-ventral pallidum pathway.

Authors:  Ornella Valenti; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2009-09-15       Impact factor: 5.176

4.  Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.

Authors:  A Fredriksson; T Archer
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

5.  Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.

Authors:  Anders Fredriksson; Trevor Archer
Journal:  Neurotox Res       Date:  2006-06       Impact factor: 3.911

6.  Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration.

Authors:  Wendy H Fasulo; Scott E Hemby
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

7.  Modulation of midbrain dopamine neurotransmission by serotonin, a versatile interaction between neurotransmitters and significance for antipsychotic drug action.

Authors:  J E Olijslagers; T R Werkman; A C McCreary; C G Kruse; W J Wadman
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

Review 8.  Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.

Authors:  Rodrigo D Paz; Sonia Tardito; Marco Atzori; Kuei Y Tseng
Journal:  Eur Neuropsychopharmacol       Date:  2008-07-23       Impact factor: 4.600

9.  Poor evidence for depolarization block but uncoupling of nigral from striatal dopamine metabolism after chronic haloperidol treatment in the rat.

Authors:  S J Chrapusta; M F Egan
Journal:  J Neural Transm (Vienna)       Date:  2005-08-05       Impact factor: 3.850

10.  Exploring neuronal bistability at the depolarization block.

Authors:  Andrey Dovzhenok; Alexey S Kuznetsov
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.